Speaker & Guest Contributor
Dr. Nicole Schwerbrock, Director of Technology Development and Commercialization at the SBTDC, assists with the business growth of knowledge-based inventions. She and her team provide strategic advice to pre-venture entities, university start-ups and small businesses in the life sciences. Dr. Schwerbrock has expertise in developing new opportunities for commercialization, building strategic relationships with the entrepreneurial community, supporting student engagement and assisting with the formation of university startup companies. She has an excellent understanding of the commercialization process, tech transfer office functions and the SBIR/STTR programs and student engagement.
Before joining the SBTDC team Dr. Schwerbrock was employed at the UNC Eshelman School of Pharmacy at Chapel Hill as an Innovation and Entrepreneurship Fellow where she was a key member of a team that engaged in identifying, supporting and promoting viable technology commercialization opportunities originating from the School. During her tenure the School spun out four companies and submitted several successful SBIR/STTR grant applications. Prior to UNC Eshelman School of Pharmacy, Dr. Schwerbrock served as an R&D scientist for both early-stage and commercial-stage pharmaceutical corporations. At Qualiber, a UNC Eshelman School of Pharmacy spinout company, she was the Senior Scientist (and sole employee) and prior to pursuing higher education, she worked at Sanofi (formerly, Hoechst AG; Frankfurt, Germany) where she learned many scientific techniques associated with pharmacology and drug testing.
Nicole is multi-lingual and -cultural, as she holds undergraduate degrees in Math and Biology (Mexico’s Alexander from Humboldt School), a Master’s in Biomedical Sciences (University of Amsterdam) and earned her PhD from the Gillings School of Global Public Health at UNC-CH followed by a post-doctoral position at UNC School of Medicine.